Government Decree No. 159 / 2022 Coll.
Government Regulation amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended
Valid
Regulation
Effective from 01.07.2022
Text versions:
01.07.2022
22.06.2022
159
GOVERNMENT REGULATION
of 1 June 2022
amending Government Regulation No 463 / 2013 Coll., on substance lists, as amended
The Government orders pursuant to § 44c (1) of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll. and Act No. 366 / 2021 Coll.:
Government Regulation No. 463 / 2013 Coll., on substance lists, as amended by Government Regulation No. 243 / 2015 Coll., Government Regulation No. 46 / 2017 Coll., Government Regulation No. 30 / 2018 Coll., Government Regulation No. 242 / 2018 Coll. and Government Regulation No. 184 / 2021 Coll., are amended as follows:
1. At the end of footnote 3, the sentence is added to the separate line:
"Commission Delegated Directive (EU) 2021 / 802 of 12 March 2021 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of new psychoactive substances methyl 3,3-dimethyl-2- {[1- (pent-4-en-1-yl) -1H-indazol-3-carbonyl] amino} butanoate (MDMB-4en-PINACA) and methyl 2- {[1- (4-fluorobutyl) -1H-indol-3-carbonyl] amino} -3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of drugs. '
2. Annex 1 shall read as follows:
"Annex No 1 to Government Regulation No 463 / 2013 Coll.
List No 1 of narcotic drugs
| Mezinárodní nechráněný název (INN) v českém jazyce | Chemický název podle IUPAC | Poznámka |
|---|---|---|
| Acetorfin | (5R,6R,7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy-6,14-ethenomorfinan-3-yl-acetát | |
| Acetyl-alfa-methylfentanyl | (RS)-N-[1-(2-fenyl-2-methylethyl)-4-piperidyl]acetanilid | |
| Acetylmethadol | (3RS)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfacetylmethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Alfameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Alfamethadol | (3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Alfa-methylfentanyl | N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid | |
| Alfa-methylthiofentanyl | N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Alfaprodin | (3RS,4SR)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát | |
| Alfentanil | N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-fenylpropanamid | |
| Allylprodin | 3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Anileridin | ethyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát | |
| Benzethidin | ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát | |
| Benzylmorfin | 3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6α-ol | |
| Betacetylmethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát | |
| Beta-hydroxyfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]piperidin-4-yl}propananilid | |
| Beta-hydroxymethylfentanyl | N-{1-[(2RS)-2-hydroxyfenethyl]-3-methylpiperidin-4-yl}propananilid | |
| Betameprodin | (3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát | |
| Betamethadol | (3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Betaprodin | (3RS,4RS)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát | |
| Bezitramid | 2,2-difenyl-4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidino]butannitril | |
| Dextromoramid | 1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin | |
| Diampromid | N-[2-(N-fenethyl-N-methylamino)propyl]propananilid | |
| Diethylthiambuten | 3-(diethylamino)-1,1-di(2-thienyl)but-1-en | |
| Difenoxin | 1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylová kyselina | |
| Difenoxylát | ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát | |
| Dihydroetorfin | (5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethanomorfinan-3-ol | |
| Dihydromorfin | 4,5α-epoxy-17-methylmorfinan-3,6α-diol | |
| Dimenoxadol | [2-(dimethylamino)ethyl]-2-ethoxy-2,2-difenyl-acetát | |
| Dimefeptanol | 6-(dimethylamino)-4,4-difenylheptan-3-ol | |
| Dimethylthiambuten | N,N,1-trimethyl-3,3-di(2-thienyl)allylamin | |
| Dioxafetyl-butyrát | ethyl-2,2-difenyl-4-morfolinobutanoát | Dioxafetylbutyrát |
| Dipipanon | (6RS)-4,4-difenyl-6-piperidinoheptan-3-on | |
| Drotebanol | (6R)-3,4-dimethoxy-17-methylmorfínan-6β,14-diol | |
| Ekgonin | kyselina (1R,2R,3S,5S)3-hydroxy-8-methyl-8-azabicyklo[3.2.1]oktan-2-karboxylová, její estery a deriváty, z kterých je možno získat ekgonin a kokain | |
| Ethylmethylthiambuten | N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin | |
| Etonitazen | 1-[2-(diethylamino)ethyl]-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol | |
| Etoxeridin | ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát | |
| Extrakt z konopí pro léčebné použití | Extrakt z konopí určeného k přípravě léčivých přípravků se standardizovaným obsahem tetrahydrokanabinolu | |
| Fenadoxon | 4,4-difenyl-6-morfolinoheptan-3-on | |
| Fenampromid | N-(1-methyl-2-piperidinoethyl)propananilid | |
| Fenazocin | (2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | |
| Fenomorfan | 17-fenethylmorfinan-3-ol | |
| Fenoperidin | ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát | |
| Fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid | |
| Furethidin | ethyl-4-fenyl-1-[2-(furfuryloxy)ethyl]piperidin-4-karboxylát | |
| Hydrokodon | 4,5α-epoxy-3-methoxy-17-methylmorfinan-6-on | |
| Hydromorfinol | 4,5α-epoxy-17-methylmorfinan-3,6α,14-triol | |
| Hydromorfon | 4,5α-epoxy-3-hydroxy-17-methylmorfinan-6-on | |
| Hydroxypethidin | ethyl-4-(3-hydroxyfenyl)-1-methylpiperidin-4-karboxylát | |
| Isomethadon | 6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on | |
| Karfentanil | methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát | |
| Klonitazen | 2-(4-chlorbenzyl)-1-[2-(diethylamino)ethyl]-5-nitro-1H-benzimidazol | |
| Kodoxim | kyselina 2-{[N-(4,5α-epoxy-3-methoxy-17-methylmorfinan-6-yliden)amino]oxy}octová | |
| Koka - list | Kokový list | |
| Kokain | (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyklo[3.2.1]oktan-2-karboxylát | |
| Koncentrát z makoviny | Poloprodukt k výrobě alkaloidů získaný technologickou úpravou makoviny | |
| Konopí extrakt a tinktura | S výjimkou látky konopí extrakt a tinktura, která obsahuje 1 % látek ze skupiny tetrahydrokanabinolů a splňuje podmínku bezpečnosti podle zákona o obecné bezpečnosti výrobků | |
| Konopí pro léčebné použití | ||
| Levofenacylmorfan | 1-fenyl-2-[9R,13R,14R)3-hydroxymorfinan-17-yl]ethan-1-on | |
| Levomethorfan | (9R,13R,14R)-3-methoxy-17-methylmorfinan | Stereoizomerní dextromethorfan [(+)-3-methoxy-17-methylmorfinan] je vyňat ze seznamu omamných látek uvedených v této příloze |
| Levomoramid | (3R)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on | |
| Levorfanol | (9R,13R,14R)-17-methylmorfinan-3-ol | Stereoizomerní dextrorfanol [(+)-3-hydroxy-17-methylmorfinan] je vyňat ze seznamu omamných látek uvedených v této příloze |
| Metazocin | (2R,6R,11R)-3,6,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-dimethano-3-banzazocin-8-ol | |
| Methadon | (6RS)-6-(dimethylamino)-4,4-difenylheptan-3-on | |
| Methadon, meziprodukt | 4-(dimethylamino)-2,2-difenylpentannitril | |
| Methyldesorfin | 4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol | |
| Methyldihydromorfín | 4,5-epoxy-6,17-dimethylmorfinan-3,6-diol | |
| Metopon | 4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on | |
| Moramid, meziprodukt | 2,2-difenyl-3-methyl-4-morfolinobutanová kyselina | |
| Methylfentanyl | N-(1-fenethyl-3-methylpiperidin-4-yl)propananilid | 3-Methylfentanyl |
| Methylthiofentanyl | N-{(3RS)-3-methyl-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | 3-methylthiofentanyl |
| Meziprodukt konopí pro léčebné použití | základně zpracovaná rostlina konopí pro léčebné použití obsahující vrcholík | |
| Morferidin | ethyl-4-fenyl-1-(2-morfolinoethyl)piperidin-4-karboxylát | |
| Morfin | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diol | |
| Morfin methobromid | 4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid | a jiné deriváty morfinu se čtyřvazným dusíkem včetně derivátů morfin-N-oxidu (i kodein-N-oxidu) |
| Morfin-N-oxid | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diol-17-oxid | |
| Desmethylprodin | 4-fenyl-1-methylpiperidin-4-yl-propanoát | MPPP |
| Myrofin | 3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6-yl-tetradekanoát | |
| Nikomorfin | 4,5α-epoxy-17-methylmorfin-7-en-3,6α-diyl-dinikotinát | |
| Noracymethadol | 4,4-difenyl-6-(methylamino)heptan-3-yl-acetát | |
| Norlevorfanol | (9R,13R,14R)-morfinan-3-ol | |
| Normethadon | 6-(dimethylamino)-4,4-difenylhexan-3-on | |
| Normorfin | 4,5α-epoxymorfin-7-en-3,6α-diol | |
| Norpipanon | 4,4-difenyl-6-piperidinohexan-3-on | |
| Opium | Kromě homeopaticky vyrobených přípravků, jejichž stupeň ředění je vyšší než D4 nebo CH2 | |
| Oripavin | 4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol | |
| Oxykodon | (5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on | |
| Oxymorfon | (5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on | |
| Parafluorfentanyl | N-(1-fenethylpiperidin-4-yl)-4'-fluorpropananilid | |
| Pheneridin | ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát | PEPAP |
| Pethidin | ethyl-4-fenyl-1-methylpiperidin-4-karboxylát | |
| Pethidin, meziprodukt A | 4-fenyl-1-methylpiperidin-4-karbonitril | |
| Pethidin, meziprodukt B | ethyl-4-fenylpiperidin-4-karboxylát | |
| Pethidin, meziprodukt C | kyselina 4-fenyl-1-methylpiperidin-4-karboxylová | |
| Piminodin | ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát | |
| Piritramid | 1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin | |
| Proheptazin | 4-fenyl-1,3-dimethylazepan-4-yl-propanoát | |
| Properidin | isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát | |
| Racemethorfan | (9RS,13RS,14RS)-3-methoxy-17-methylmorfinan | |
| Racemoramid | (3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on | |
| Racemorfan | (9RS,13RS,14RS)-17-methylmorfinan-3-ol | |
| Remifentanil | methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát | |
| Sufentanil | N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Tapentadol | 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol | |
| Thebain | 4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien | |
| Thebakon | (5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát | |
| Thiofentanyl | N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid | |
| Tilidin | ethyl-(1RS,2RS)-2-(dimethylamino)-1-fenylcyklohex-3-en-1-karboxylát | |
| Trimeperidin | (RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Including the isomers of the narcotic substances listed in this list, the esters and ethers of the narcotic substances listed therein and the salts of the narcotic substances listed therein, including salts of isomers, esters and ethers in all cases where such salts may exist. '
3. Annexes 3 and 4 shall read as follows:
"Annex No. 3 to Government Decree No. 463 / 2013 Coll.
List No 3 Narcotics
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Acetylbenzylfentanyl | NSC 73750; benzylacetylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid | |
| Acetylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid | ||
| Acryloylfentanyl | Acrylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid | |
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | ||
| AP-237 | bucinnazin; 1-N-butyryl-4-cinnamylpiperazine; | 1-[4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| Benzodioxolfentanyl | BZD-F; benzodioxole-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2H-1,3-benzodioxol-5-karboxamid | |
| Benzoylbenzylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid | ||
| Benzoylfentanyl | fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid | |
| Benzylfentanyl | Benzyl-F; R4129 | N-fenyl-N-[1-(fenylmethyl)piperidin-4-yl]propanamid | |
| Benzylfuranylfentanyl | Benzyl FuF | N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid | |
| Bromadolin | U4793e;U47931E | 4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid | |
| Butonitazen | 2-[(4-butoxyfenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazol-1-ethanamin | ||
| 4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| Cyklopentylfentanyl | Cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
| Cyklopropylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | ||
| Desomorfin | 4,5α-epoxy-17-methylmorfinan-3-ol | ||
| Despropionyl-2-fluor fentanyl | N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Despropionyl-4-fluor fentanyl | N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Etazen | etodesnitazene | 2-[2-[(4-ethoxyfenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamin | |
| Etorfin | (5R,6R,7R, 14R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorfinan-3-ol | ||
| Fentanyl butanamid analog | Butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3-Fenylpropanoylfentanyl | β'-fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-3-fenylpropanamid | hydrocinnamoylfentanyl |
| Flunitazen | N,N-diethyl-2-{2-[(4-fluorfenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethanamin | ||
| 4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorfenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
| 4-Fluor-cyklopropylbenzylfentanyl | para-fluorcyklopropylbenzyl-fentanyl | N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid | |
| 2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
| 3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 3-FF, m-FF |
| 4-Fluorfuranylfentanyl | para-fluorfuranylfentanyl; 4F-furanylfentanyl | N-(4-fluorfenyl)-N-(1-fenethylpiperidin-4-yl)furan-2-karboxamid | |
| 4-Fluorisobutyrfentanyl | 4F-iBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 3-Fluormethoxyacetylfentanyl | ortho-fluormethoxyacetyl-fentanyl | N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Furanylfentanyl | FU-F; 2-furanoylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | |
| (iso)Butyryl-F-fentanyl N-benzyl analog | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | ||
| Heroin | (5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát | ||
| 4-hydroxybutyrfentanyl | 4-HO-BF; para-hydroxybutyrylfentanyl | N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid | |
| Isopropyl-U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid | ||
| Isotonitazen | N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethanamin | ||
| Ketobemidon | 1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on | ||
| Konopí | S výjimkou konopí pro léčebné použití uvedené v seznamu č. 1 | ||
| Krotonylfentanyl | (2E)-N-fsayl-N-[1-(2-fenylethyl)pipendin-4-yl]-2-butenamid | ||
| Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]butanamid | |
| 2-Methylacetylfentanyl | o-methylacetylfentanyl | N-(2-methylfenyl)-N-[1-(2-fenylethyl)-piperidin-4-yl]-acetamid | |
| 2-Methyl-AP-237 | 2-methyl-bucinnazin | 1-[2-methyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| 3,4-Methylendioxy-U-47700 | 3,4-MDO-U-47700; 3,4-MDU-47700; MDU-47; MDU-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methylbenzo[d][1,3]dioxol-5-karboxamid | |
| α-Methylfentanyl butanamid analog | BF; B-F | 2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
| 3-Methylkrotonylfentanyl | β'-methylkrotonylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid | |
| Metodesnitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]benzimidazol-1-yl]ethanamin | ||
| Metonitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamin | ||
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | ||
| N-methyl U-47931E | N-methylbromadolin | 4-brom-N-(2-(dimethylamino)cyklohexyl)-N-methylbenzamid | |
| OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Piperidylthiambuten | pipendinohton, PBN, 127C49 | 1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)piperidin | |
| Pryskyřice z konopí | |||
| Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
| Tetramethylcyklopropanfentanyl | TMCP-fentanyl; TMCP-F | Ν-fenyl-Ν-[1-(2-fenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyklopropan-1-karboxamid | |
| Thiofenfentanyl | 2-thiofuranyl fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid | |
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-48800 | 2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-50488 | 3,4-dichlor-N-methyl-N-[2-(1-pyrrolidinyl)cyklohexyl] benzenacetamid | ||
| U-51754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | ||
| Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl pentanamid analog |
Including salts of narcotic substances listed in this group in all cases where such salts may exist.
Příloha č. 4
Annex No. 4 to Government Decree No. 463 / 2013 Coll.
List No 4 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| 1-(Cyklohexylmethyl)-2-[(4-ethoxyfenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-karboxamid | |||
| (+)-Lysergid | LSD, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 1-(2-(Methylamino)propanoyl)naftalen | AMAPN | 2-(methylamino)-1-(naftalen-1-yl)propan-1-on | |
| 1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
| 1-Nafýron | 1-naphyrone | 1-naftalen-1-yl-2-pyrrolidin-1-yl-pentan-1-on | |
| 1p-LSD, 1P-LAD | diethylamid kyseliny 1-propionyl lysergové; (6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid | ||
| 2,3-Dimethylmetkathinon | 2,3-DMMC | 1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2,3-Methylendioxymethkathinon | 2,3-MDMC | 1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on | |
| 2,4,5-Trimethylmethkathinon | 2,4,5-TMMC | ||
| 2,4,6-Trimethoxyamfetamin | TMA-6 | 1-(2,4,6-trimethoxyfenyl)propan-2-amin | |
| 2,4-Dimethylethkathinon | 2,4-DMEC | 1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on | |
| 2,4-Dimethylmetkathinon | 2,4-DMMC | 1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2',4'-Dimethyl-α-pyrrolidinpropiofenon | 2,4-DMPPP | 1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on | |
| 2,5-Dimethoxy-4-chloramfetamin | DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-jodamfetamin | DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | |
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | Cimbi-36 | |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | 2C-C-NBOMe | |
| 25I-NBF; 25I-NB2F; 2C-I-NBF, NBF-2C-I; Cimbi-21 | 2-(4-jod-2,5-dimethoxyfenyl)-N[(2-fluorfenyl)methyl]ethylamin | ||
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-I-NBOH; Cimbi-27 | |
| 251-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N[(2-methoxyfenyl)methyl]ethanamin | NBOMe-2C-I | |
| 2-Brommethkathinon | 2-BMC | (RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on | |
| 2C-B-FLY | 2C-B-FLY | 2-(4-brom-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-8-yl)ethanamin | |
| 2C-D | 2C-D | 2,5-dimethoxy-4-methylfenethylamin | LE-25 |
| 2C-E | 2C-E | 2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin | |
| 2-Ethylmethkathinon | 2-EMC | (RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on | |
| 2-Fluoramfetamin | 2-FA | 1-(2-fluorfenyl)propan-2-amin | |
| 2-Fluordeschlorketamin | 2-Fl-2'-Oxo-PCM, fluoro-ketamine 2-FDCK, 2-FDK, 2-FK | 2-(2-fluorfenyl)-2-methylamino-cyklohexanon | |
| 2-Fluorethamfetamin | 2-FEA; 2-fluoroethamphetamine | N-ethyl-1-(2-fluorfenyl)propan-2-amin | |
| 2-Fluorethkathinon | 2-FEC | 1-(2-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Fluormethamfetamin | 2-FMA | (RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin | |
| 2-Fluormethkathinon | 2-FMC | 1-(2-fluorfenyl)-2-(methylamino)propan-1-on | |
| 2F-QMPSB; SGT-13 | 8-chinolinyl-3-[(4,4-difluoφiperidin-1-yl)sulfonyl]-4-methylbenzoát | ||
| 2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
| 2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
| 2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
| 2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | ||
| 2-Methoxymethylon | N-methyl-bk-MMDA-2 | 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-on | |
| 2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
| 2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
| 2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
| 2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
| 2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
| 2-Pyrrolidin-3-methoxy-propiofenon | α-PPP-MeO; PMeOPP | 3-methoxy-1-fenyl-2-(pyrrolidin-1-yl)propan-1-on | |
| 3-(4-Hydroxymethylbenzoyl)-1-pentylindol | Tai High | [4-(hydroxymethyl)fenyl]-(1-pentyl-1H-indol-3-yl)methanon | |
| 3-(p-Methoxybenzoyl)-N-methylindol | (4-methoxyfenyl)(l -methyl-1H-indol-3-yl)methanon | ||
| 3',4'- Methylendioxy-α-methyl PPP | MDMPP | 1-(3,4-methylendioxyfenyl)-2-methyl-2-pyrrolidinylpropan-1-on | |
| 3,4-Dichlorethkathinon | 3,4-DCEC; | 1-(3,4-dichlorfenyl)-2-(ethylamino)propan-1-on | |
| 3,4-Dichlormethylfenidát | 3,4-CTMP | methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-pipendin-2-yl]acetát | |
| 3,4-Dichlor-N,N-cyklohexylmethylmeth-kathinon | 3,4-DCCHMMC | 2-(cyklohexylmethylamino)-1-(3,4-dichlorfenyl)propan-1-on | |
| 3,4-Dimethoxy-α-PHP | 3,4-DMeO-α-PHP | 1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)hexan-1-on | |
| 3,4-Dimethylethkathinon | 3,4-DMEC | 1-(3,4-dimethylfenyl)-2-(ethylamino)propan-1-on | |
| 3,4-Dimethylmetkathinon | 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 3,4-Dimethyoxy-α-pyrrolidinovalerofenon | 3,4-DMeO-α-PVP | 1-(3,4-dimethoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 3,4-Methylendioxypyrovaleron | MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | MDPK |
| 3',4'-Methylendioxy-α-pyrrolidinbutyro-fenon | MDPBP | (RS)-1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)butan-1-on | |
| 3 ',4'-Methylendioxy-α-PPP | MDPPP | 1-(3,4-methylendioxyfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 3 -Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
| 3-Ethylmethkathinon | 3-EMC | (RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on | |
| 3F-Fenmetrazin | 3-FPM; PAL-593 | 2-(3-fluorofenyl)-3-methylmorfolin | |
| 3-Fluoramfetamin | 3-FA | 1-(3-fluorfenyl)propan-2-amin | |
| 3-Fluorethamfetamin | 3-FEA; 3-fluoroethamphetamine | N-ethyl-1-(3-fluorfenyl)propan-2-amin; N-ethyl-3-fluoramfetamin | |
| 3-Fluorethkathinon | 3-FEC | 1-(3-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Fluormethamfetamin | 3-FMA | (RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin | |
| 3-Fluormethkathinon | 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | |
| 3-Fluor-α-PVP | 3F-α-PVP; 3F-PVP | 1-(3-fluorfenyl)-2-(1-pyrrolidin)pentan-1-on | 3-Fluor-α-PVP |
| 3-Hydroxyfenazepam | 3-HOP, HPNZ, 3-oxyfenazepam, 3 -hy droxy fenazepam | 7-brom-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| 3-Hydroxyfencyklidin | 3-HO-PCP; 3-hydroxyphencyclidine | 3-[1-(piperidin-1-yl)cyklohexyl] fenol | |
| 3-Chloramfetamin | 3-CA | 1-(3-chlorfenyl)propan-2-amin | |
| 3-Chlorethkathinon | 3-CEC | 1-(3-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Chlormethamfetamin | 3-CMA | 1-(3-chlorfenyl)-N-methylpropan-2-amin | |
| 3-Chlormethkathinon | 3-CMC | 1-(3-chlorfenyl)-2-(methylamino)propan-1-on | |
| 3-Chlorpentedron | 3-CPD | 1-(3-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 3-MAPB | 1-(benzofuran-3-yl)-N-methylpropan-2-amin | ||
| 3-Methoxy eticyklidin | 3-MeO-PCE | N-ethyl-1-(3-methoxyfenyl)cyklohexan-1-amin | |
| 3-Methoxy fencyklidin | 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | |
| 3-Methoxymethkathinon | 3-MeOMC | 1-(3-methoxyfenyl)-2-(methylamino)propan-1-on | |
| 3-Methyl-4-fluormethkathinon | 3-Methylflefedron | 1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on | |
| 3-Methylamfetamin | 3-MA | (2RS)-1-(3-methylfenyl)propan-2-amin | |
| 3-Methylethkathinon | 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | |
| 3-Methylmetamfetamin | 3-MMA | 1-(3-methylfenyl)-N-methylpropan-2-amin | |
| 3-Methylmetkathinon | 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | |
| 3-Methyl-N,N-dimethylkathinon | 3-MDMC | 1-(3-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 3-Methyl-N-ethylnorpentedron | 3-MEAP | 2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on | |
| 3-Methylthioamfetamin | 3-MTA | (2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin | |
| 4'-Fluor-4-methylaminorex | 4-FPO; p-F-4-methylaminorex | 5-(4-fluorfenyl)-4,5-dihydro-4-methyl-2-oxazolamin | |
| 4'-Methyl-N-isopropylpentedron | 4'-methyl-NiPP | 1-(4-methylfenyl)-2-(1-methylethylamino)pentan-1-on | |
| 4'-Methyl-α-pyrrolidinbutyrofenon | MPBP | (RS)-1-(4-methylfenyl)-2-(pyrrohdin-1-yl)butan-1-on | |
| 4'-Methyl-α-pyrrolidinisohexanofenon | 4'-methyl-α-PiHP | 4-methyl-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4'-Methyl-α-pyrrolidinpropiofenon | 4'-methyl-α-PPP; MPPP | (RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4'-Ethyl-α-PVP | 4'-ethyl-α-pyrrolidinopentiofenon | 1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Acetoxy-N-methyl-N-ethyltryptamin | 4-AcO-MET | {3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát | |
| 4-Bromethkathinon | 4-BEC | 1-(4-bromfenyl)-2-(ethylamino)propan-1-on | |
| 4-Brommethkathinon | 4-BMC | (RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on | Brefedron |
| 4-Brom-α-pyrrolidinvalerofenon | 4Br-α-PVP | 1-(4-bromfenyl)-2-pyrrolidin-1-yl-pentan-1-on | |
| 4-Brom-α-pyrrolidinpropiofenon | 4Br-α-PPP; pBPPP, 4Br-PPP | 1-(4-bromfenyl)-2-pyrrolidin-1-yl-propan-1-on | |
| 4-Ethylethkathinon | 4-EEC | 2-(ethylamino)-1-(4-ethylfenyl)propan-1-on | |
| 4-Ethylmethkathinon | 4-EMC | (RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on | |
| 4F-Fenmetrazin | 4-FPM | 2-(4-fluorofenyl)-3-methylmorfolin | |
| 4-Fluoramfetamin | 4-FA | 1-(4-fluorfenyl)propan-2-amin | |
| 4-Fluorbufedron | 1-(4-fluorfenyl)-2-(methylamino)butan-1-on | ||
| 4-Fluorethkathinon | 4-FEC | 1-(4-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Fluorethylfenidát | 4F-EPH; p-fluoroethylphenidate | ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | |
| 4-Fluorkathinon | 4-FC | 2-amino-1-(4-fluorfenyl)-propan-1-on | |
| 4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
| 4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron |
| 4-Fluormethylfenidát | 4F-MPH; 4-FMPH | Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | 4F-TMP |
| 4-Fluor-N-ethylbufedron | 4F-NEB | 2-(ethylamino)-1-(4-fluorfenyl)butan-1-on | |
| 4-Fluor-N-ethylpentedron | 4F-NEP; 4-fluor-α-ethylamino-pentiofenon | 2-(ethylamino)-1-(4-fluorfenyl)pentan-1-on | |
| 4-Fluor-N-isopropylnorpentedron | 4F-IPV; 4F-NPP; 4F-NIPP | 1-(4-fluorfenyl)-2-(1-methylethylamino)pentan-1-on | |
| 4-Fluorpentedron | 4-FPD; 4-F-pentedron | 1-(4-fluorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Fluor-α-pyrrolidinvalerofenon | 4-fluoro-α-PVP; 4F-PVP; O-2370 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Fluor-α-pyrrolidinbutiofenon | 4F-PBP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)butan-1-on | |
| 4-Fluor-α-pyrrolidinenanthofenon | 4F-α-PEP; 4F-PV8 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)heptan-1-on | |
| 4-Fluor-α-pyrrolidinhexanofenon | 4-F-α-PHP | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)hexan-1-on | |
| 4-Fluor-α-pyrrolidinisohexanofenon | 4F-alpha-PHiP; 4F-α-PiHP | 1-(4-fluorfenyl)-4-methyl-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Fluor-α-pyrrolidinoktanofenon | 4F-α-POP; 4F-PV9 | 1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)oktan-1-on | |
| 4F-MDMB-BICA | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 4F-MDMB-BINACA; 4F-ADB | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 4-F-α-PVP piperidin analog | 1-(4-fluorfenyl)-2-(1-piperidyl)pentan-1-on | ||
| 4-HTMPIPO | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on | ||
| 4-Hydroxy-N-methyl-N-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Methylcybin |
| 4-Hydroxy-N-methyl-N-isopropyl tryptamin | 4-HO-MiPT | 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol | Miprocin |
| 4-Chlor-α-pyrrolidinovalerofenon | 4-Cl-α-PVP | 1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Chloramfetamin | 4-CA | 1-(4-chlorfenyl)propan-2-amin | PCA |
| 4-Chlordiazepam | Ro5-4864, chlorodiazepam | 7-chlor-5-(4-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| 4-Chlorethkathinon | 4-CEC | 1-(4-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Chlorisopropylkathinon | 4-CIC; clipredrone, | 1-(4-chlorfenyl)-2-(isopropylamino)propan-1-on | |
| 4-Chlormethamfetamin | 4-CMA | 1-(4-chlorfenyl)-N-methylpropan-2-amin | p-CMA |
| 4-Chlormethkathinon | 4-CMC | 1-(4-chlorfenyl)-2-(methylamino)propan-1-on | Clefedron |
| 4-Chlor-N,N-dimethylkathinon | 4-CDC; 4-CDMD | 1-(4-chlorfenyl)-2-(N,N-dimethylamino)propan-1-on | |
| 4-Chlor-N-butylkathinon | 4-CBC | 2-(butylamino)-1-(4-chlorfenyl)propan-1-on | 4-Chlorbutylkathinon |
| 4-Chlorpentedron | 4-CPD | 1-(4-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlor-α-pyrrolidinpropiofenon | 4-chlor-α-PPP | 1-(4-chlorfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4-MAPB | 4-MAPB | 1-(benzofuran-4-yl)-N-methylpropan-2-amin | |
| 4-Methoxy-α-pyrrolidinbutiofenon | 4-MeO-α-PBP; 4-MOPBP | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)butan-1-on | |
| 4-Methoxy-α-pyrrolidinenanthofenon | 4-MeO-α-PEP; 4-MeO-α-PV8 | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)heptan-1-on | |
| 4-Methoxy-α-pyrrolidinoktanofenon | 4-methoxy α-POP; 4-MeO-α-PV9 | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)oktan-1-on | |
| 4-Methoxy-α-pyrrolidinpentiofenon | 4-MeO-α-PVP | 1-(4-methoxyfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4'-Methoxy-α-pyrrolidinpropiofenon | 4'-Methoxy-α-PPP; MOPPP | (RS)-1-(4-methoxyfenyl)-2-(1-pyrrolidinyl)propan-1-on | |
| 4-Methylamfetamin | 4-MA | (2RS)-1-(4-methylfenyl)propan-2-amin | |
| 4-Methylbufedron | 4-Me-MABP | 2-(methylamino)-1-(4-methylfenyl)butan-1-on | |
| 4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methylkathinon | Normefedron; 4-MC | 2-amino-1-(4-methylfenyl)propan-1-on | |
| 4-Methylmetamfetamin | 4-MMA | 1-(4-methylfenyl)-N-methylpropan-2-amin | |
| 4-Methylmetkathinon | Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methyl-N,N-diethylkathinon | 2-diethylamino-1-(4-methylfenyl)propan-1-on | ||
| 4-Methyl-N,N-dimethylkathinon | 4-MDMC | 1-(4-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 4-methyl-N-benzylkathinon | (4-MBC) | (±)-1-(4-methylfenyl)-2-(benzylamino)propan-1-on | |
| 4-Methyl-N-ethylnorpentedron | 4-MEAP | 2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on | |
| 4-Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
| 4'-Methyl-α-pyrrolidinhexanofenon | MPHP | (RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)hexan-1-on | |
| 4-MPD | 1-(4-methylfenyl)-2-methylamino-pentan-1-on | ||
| 5 - Aminopropylindol | 5-API | 5-(2-aminopropyl)indol | |
| 5-BPDi; indanyl-α-PHP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| 5C-AKB48; 5C-APINACA | N-(1-adamantyl)-1-(5-chlorpentyl)indazol-3-karboxamid | ||
| 5Cl-AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-chlorpentyl)indazol-3-karboxamid | ||
| 5Cl-MDMB-PINACA; 5Cl-ADB | methyl 2-{[1-(5-chlorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát | ||
| 5-Cl-pentyl JWH 018 indazol analog | 5Cl-THJ-018; 5Cl-JWH-018-N, THJ-018 chloro analogue | [1-(5-chlorpentyl)-1H-indazol-3-yl](naftalen-1-yl)methanon | |
| 5 -Dihydrobenzofuranpyrovaleron | 5-DBFPV; MBPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin | ||
| 5F-3,5-AB-PFUPPYCA; 5F-3,5-AB-FUPPYCA, AZ-037 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid | ||
| 5F-5,3-AB-PFUPPYCA; 5F-AB-FUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-5-(4-fluorfenyl)-1H-pyrazol-3-karboxamid | ||
| 5F-AB-P7AICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | ||
| 5F-AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AKB57 | adamantan-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-AMBICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-AMB-PICA | methyl (2S)-2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methylbutanoát | ||
| 5F-AMB-PINACA; 5F-AMB | methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP | |
| 5F-A-P7AICA | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | ||
| 5F-APP-PICA | N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-APP-PINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluorpentyl)indazol-3-karboxamid | ||
| 5F-CUMYL-PEGACLONE | 5-(5-fluorpentyl)-2-(1-methyl-1-fenylethyl)-pyrido[4,3-b]indol-1-on | ||
| 5F-EDMB-PINACA | ethyl 2-{[1-(5-fluorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát | ||
| 5F-EMB-PINACA | ethyl 2-[[1-(5-fluorpentyl)indazol-3-karbonyl]amino]-3-methyl-butanoát | ||
| 5F-JWH-398; CL-2201; JWH-398 N-5-fluor pentyl analog | (4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon | ||
| 5F-MDMB-P7AICA | methyl-2-{[1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethyl butanoát | ||
| 5F-MDMB-PICA; 5F-MDMB-2201 | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 5F-MDMB-PINACA; 5F-ADB | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 5F-NNEI-2 | 1-(5-fluorpentyl)-N-(naftalen-2-yl)-1H-indol-3-karboxamid | ||
| 5F-PB-22 indazol analog | chinolin-8-yl 1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-PB-22; 5F-QUPIC | 8-chinolinyl ester kyseliny 1-(5-fluorpentyl)-1H-indol-3-karboxylové | ||
| 5-F-pentyl-3-pyridinoylindol | [1-(5-fluorpentyl)-1H-indol-3-yl] (pyridin-3-yl)methanon | ||
| 5F-PY-PICA | 1-(5-fluorpentyl)-3-(pyrrolidin-1-karbonyl)-1-H-indol | ||
| 5F-PY-PINACA | [1-(5-fluorpentyl)indazol-3-yl]-pyrrolidin-1-yl-methanon | ||
| 5F-SDB-005 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát | ||
| 5F-SDB-006 | N-benzyl-1-(5-fluorpentyl)-l H-indol-3-karboxamid | ||
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyklopropyl)methanon | XLR-11 | |
| 5-MAPB | 1-(benzofuran-5-yl)-N-methylpropan-2-amin | ||
| 5-MeO-AMT | 5 -methoxy-α-methyltryptamin | ||
| 5-MeO-DALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin | ||
| 5-MeO-MiPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-methoxy-N-methyl-N-iso-propyl tryptamin | ||
| 5-MethoxymethyIon | N-methyl-bk-MMDA-5 | 1-(7-methoxybenzo[d] [1,3]dioxol-5-yl)-2-(methylamino)propan-1-on | |
| 5-PPDi | 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-on | ||
| 6-APB | 6-(2-aminopropyl)benzofuran | ||
| 6-EAPB | 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin | ||
| 6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amin | ||
| 7-MAPB | 1-(benzofuran-7-yl)-N-methylpropan-2-amin | ||
| A-796,260 | [1-(2-morfolin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| A-796,260 izomer | ((E)-1-(1-(2-morfolm-1-yl)ethyl)indol-3-yl)-3,4,4-tnmethylpent-2-en-1-on | ||
| A-834,735 | 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| A-836,339 | N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-yliden]-2,2,3,3-tetramethylcyklopropan-karboxamid | ||
| AB-005 | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)-methanon | ||
| AB-005 azepan izomer | (1-(1-methylazepan-2-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| AB-FUBINACA 2-fluorbenzyl izomer | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-[(2-fluorfenyl)methyl]-1H-indazol-3-karboxamid | ||
| AB-CHMFUPPYCA; 3,5-AB-CHMFUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid | ||
| AB-CHMINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-l(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid | ||
| AB-PINACA N-(2-fluorpentyl) izomer | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorpentyl)-1H-indazol-3-karboxamid | ||
| Adamantyl-THPINACA | N-(1-adamantyl)-1-(tetrahy dropyran-4-ylmethyl)indazol-3-karboxamid | ||
| ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| ADB-CHMICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-1H-indol-3-karboxamid | ||
| ADB-CHMINACA | N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karbox-amid | ||
| ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karboxamid | ||
| ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-\H- indazol-3-karboxamid | ||
| Adinazolam | U 41123 | 1-(8-chlor-6-fenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethan amin | |
| A-CHMINACA | N-(1-adamantyl)-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| AKB-57 | Adamant-1-yl-1-pentylindazol-3-karboxylát | ||
| AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid | 6-allyl-6-nor-LSD | |
| Alprazolam triazolbenzofenon derivát | (2-(3-(aminomethyl)-5-methyl-4-H-1,2,4-triazol-4-yl)-5-chlorfenyl)(fenyl)methanon | ||
| AM-1220 | 1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naftyl)-methanon | ||
| AM-1220 azepan izomer | 1-(1-methylazepan-3-yl)-1H-indol-3-yl] (naftyl)methanon | ||
| AM-1248 | adamant-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanon | ||
| AM-1248 azepan izomer | adamant-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanon | ||
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| AM-2201 benzimidazol analog; FUBIMINA | (1-(5-fluorpentyl)-1H-benzo[d]imidazol-2-yl)(naftalen-1-yl)methanon | ||
| AM-2201 indazol karboxamid analog | N-1-naftalenyl-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| AM-2232 | 5-[3-(1-naftoyl)-1H-indol-1-yl]pentannitril | ||
| AM-2233 | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodbenzoyl)indol | ||
| AM-6527 | 1-pentyl-N-(naftalen-1-yl)-1H-indol-3-karboxamid | ||
| AM-6527 5-fluorpentyl derivát | 1-(5-fluorpentyl)-N-(naftalen-1-yl)-1H-indol-3-kaboxamid | ||
| AM-679 | (2-iodfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| AM-694 | 1-[(5-fluorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon | ||
| AM-694 (ethyl nahrazuje iod) | 1-(5-fluorpentyl)-3-(2-ethylbenzoyl)indol | ||
| AM-694 (methyl nahrazuje iod) | 1-(5-fluorpentyl)-3-(2-methylbenzoyl)indol | ||
| AM-694 chlor derivát | 1-[(5-chlorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon | ||
| AMB-4en-PICA | methyl-3-methyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-karboxamido]butanoát | ||
| AMB-FUBICA | methyl 2-[[1-[(4-fluorfenyl)methyl]indol-3-karboxamid]-3-methylbutanoát | ||
| AMB-FUBINACA; FUB-AMB | Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát | MMB-FUBINACA | |
| AMB-CHMICA | Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát | ||
| AMB CHMINACA | methyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát | ||
| APICA; SDB-001, 2NE1 | N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid | ||
| APINACA | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | AKB48 | |
| APP BINACA | N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-butyl-1H-indazol-3-karboxamid | ||
| APP-FUBINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| APP-CHMINACA | N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(cyklohexylmethyl)indazol-3-karboxamid | ||
| bk-2C-B; βk-2C-B | 2-amino-1-(4-brom-2,5-dimethoxyfenyl)ethan-1-on | ||
| bk-IVP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-on | ||
| bk-PBDB | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-on | ||
| bk-PMA | 2-amino-1-(4-methoxyfenyl)propan-1-on | ||
| BMDB | 2-benzylamino-1-(3,4-methylendioxyfenyl)butan-1-on | ||
| BMDP; 3,4-MDBC | 2-benzylamino-1-(3,4-methylendioxyfenyl)propan-1-on | ||
| Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
| Bromazolam | 8-brom-6-fenyl-1-methyl-4H-benzo[f][1,2,4]triazol[4,3-a][1,4]diazepin | ||
| Bromo-Dragonfly | (2R)-1-(4-bromfuro[2,3-f][1]benzofuran-8-yl)propan-2-amin | ||
| Butylon | Bk-MBDB | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on | |
| CBL-018 | naftalen-1-yl 1-pentyl-1H-indol-3-karboxylát | ||
| CP 47,497 | 2-[(1S,3R)-3-hydroxycyklohexyll-5-(2-methyloktan-2-yl)fenol | ||
| CP 47,497 (C8 + C2) | 2-((1S,3R)-3-hydroxycyklohexyl)-5-(2-methylnonan-2-yl)fenol; 2-((1S,3R)-3-hydroxycyklohexyl)-5-(dekan-3-yl)-fenol | 1,1-dimethyl a 1-ethyl derivát C8-homologu | |
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 | |
| CUMYL-4CN-B7AICA | 1-(4-kyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid | ||
| CUMYL-4CN-BINACA; SGT-78 | 1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid | ||
| CUMYL-5F-P7AICA | 1-(5-fluorpentyl)-N-(2-fenylpropan-2-yl)-1H-pyrrol[2,3-b]pyridin-3-karboxamid | ||
| CUMYL-5FPICA | 1-(5-fluorpentyl)-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-5FPINACA | 1-(5-fluorpentyl)-N-(1-methyl-1-fenyethyl)-1H-indazol-3-karboxamid | ||
| CUMYL-BICA | 1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-CH-MEGACLONE | 5-(cyklohexylmethyl)-2-(1-methyl-1-fenyl-ethyl)pyrido[4,3-b]indol-1-on | ||
| CUMYL-PEGACLONE; SGT-151 | 2-(1-methyl-1-fenylethyl)-5-pentyl-pyrido[4,3-b]indol-1-on | ||
| CUMYL-PICA | 1-pentyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid | ||
| CUMYL-PINACA | 1-pentyl-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid | ||
| CUMYL-THPINACA | N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1-H-indazol-3-karboxamid | ||
| DBZP | 1,4-dibenzylpiperazin | ||
| Deschloretizolam | ETZ-2; etizolam-2 | 2-ethyl-9-methyl-4-fenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Deschlorketamin | 2-(methylamino)-2-fenylcyklohexan-1-on | ||
| Deschlor-N-ethyl-ketamin | O-PCE; 2-Oxo-PCE, eticyclidone | 2-(ethylamino)-2-fenylcyklohexan-1-on | |
| Dibutylon | Bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon | Methylbutylon |
| Diclazepam | 2-chlorodiazepam | 7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | Ro 5-3448 |
| Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl] amin | |
| Difenidin | DPD; 1,2-DEP; DIPH | 1-(1,2-difenylethyl)piperidin | AC1L4H21 |
| Difludiazepam | Ro 07-4065 | 7-chlor-5-(2,6-difluorfenyl)-1-methyl-3H-1,4-benzodiazepin-2-on | |
| Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylpentedron | DL-4662 | 1-(3,4-dimethoxyfenyl)-2-(ethylamino)pentan-1-on | |
| Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethoxymetamfetamin | STP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
| Dimethoxypropylthiofenethylamin | 2C-T-7 | [4-(propylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethylheptyltetrahydrokanabinol | DMHP | 3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Dimethylon | Bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-on | 3,4-methylendioxydi- methylkathinon |
| Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
| Dipentylon | 2-(dimethylamino)-3΄,4΄-(methylendioxy)valerophenone | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-pentan-1-on | |
| DMBA-CHMINACA | 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethylbutanová kyselina | ||
| EAM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl]-(4-ethyl-naftalen-1-yl)methanon | ||
| Efenidin | NEDPA; ephenidine; EPE | N-ethyl-1,2-difenylethylamin | |
| EG-018 | naftalen-1-yl(9-pentyl-9H-karbazol-3-yl)methanon | ||
| EG-2201 | (9-(5-fluorpentyl)-9H-karbazol-3-yl)(naftalen-1-yl)methanon | ||
| EMB-FUBINACA | Ethyl 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3-methyl-butanoát | ||
| Ephylon | MDEVP; bk-EBDP | 1-(benzo[d] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on | N-ethyl-pentylon |
| Ethkathinon | Ethylpropion; N-ethylcathinone; ETH-CAT | 2-ethylamino-1-fenyl-propan-1-on | |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid | ||
| Ethylfenidát | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | ||
| Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Etizolam | AHR 3219; Depas | 4-(2-chlorfenyl)-2-ethyl-9-methyl-67/-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Etryptamin | 3-(2-aminobutyl)indol | ||
| Eutylon | bk-EBDB, N-Ethylbutylone | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-on | |
| FDU-PB-22 | 1-naftyl 1-[(4-fluorfenyl)methyl]indol-3-karboxylát | ||
| Fenibut | phenibut | 4-amino-3-fenylbutanová kyselina | |
| Flualprazolam | Ro 11-5073/000 | 8-chlor-6-(2-fluorfenyl)-1-methyl -4H- [1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| Flubromazepam | 7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Flubromazolam | 8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]triazolo-[4,3a] [1,4]benzodiazepin | ||
| Fluklotizolam | 2-chlor-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4] diazepin | ||
| Flunitrazolam | 6-(2-fluorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | ||
| Fonazepam | Ro 05-4435 | 5-(2-fluorfenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-on | |
| FUB-144 | [1-[(4-fluorfenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| FUB-AKB48 | N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| FUB-JWH-018 | (1-(4-fluorbenzyl)-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| FUB-NPB-22 | chinolin-8-yl-(4-fluorbenzyl)-1H-indazol-3-karboxylát | ||
| FUB-PB-22 | chinolin-8-yl-1-(4-fluorbenzyl)-1H-indol-3-karboxylát | ||
| Hexedron | β-propylmethcathinone | 2-(methylamino)-1-fenylhexan-1-on | |
| Hexylon | βk-MBDH | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)hexan-1-on | |
| HU-210 | (6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloktan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | ||
| HU-331 | 3S,4R-p-benzochinon-3-hydroxy-2-p-mentha-(1,8)-dien-3-yl-5-pentyl | ||
| Hydroxytenamfetamin | (2R,S)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| Indapyrofenidon | 1-(2,3-dihydro-1H-inden-5-yl)-2-fenyl-2-(pyrrolidin-1-yl)-ethanon | ||
| Ioddimethoxyfenethylamin | 2C-I | (4-iod-2,5-dimethoxyfenylethyl)amin | |
| Isohexedron | 4-methyl-2-(methylamino)-1-fenylpentan-1-on | ||
| Isopropylfenidát | IPPD | isopropyl2-fenyl-2-(2-piperidyl)acetát | |
| JTE-907 | N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydrochinolin-3-karboxamid | ||
| JWH 018 N-5-brompentyl derivát | [1-(5-brompentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH 018 N-5-chlorpentyl derivát | [1-(5-chlorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH-007 | 1-pentyl-2-methyl-3-(1-naftoyl)indol | ||
| JWH-018 | (naftalen-1-yl)(1 -pentyl-1H-indol-3-yl)methanon | ||
| JWH-018 adamantoyl derivát; AB-001 | 1-pentyl-3-(adamant-1-oyl)indol | ||
| JWH-018 cyklohexymethyl derivát | [1-(cyklohexylmethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| JWH-018 chinolinkarboxylát analog; PB-22 | chinolin-8-yl-1-pentyl-1H-indol-3-karboxylát | ||
| JWH-018 indazol analog | 1-naftalenyl(1-pentyl-1H-indazol-3-yl)-methanon | ||
| JWH-019 | 1-hexyl-3-(1-naftoyl)indol | ||
| JWH-022 | naftalen-1-yl(2-(pent-4-enyl)-1H-indol-3-yl)methanon | ||
| JWH-030 | naftalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanon | ||
| JWH-071 | (1-ethyl-1H-indol-3-yl)-1-naftalenyl-methanon | ||
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-073 methyl derivát | 1-butyl-3-(1-(4-methyl)naftoyl)indol) | ||
| JWH-081 | (4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 pentenyl 2-methylindol derivát | (4-methylnaftalen-1-yl)(2-methyl 1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-122 pentenyl derivát | (4-methylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon | ||
| JWH-145 | naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)methanon | ||
| JWH-182 | 1-pentyl-3-(4-propyl-1-naftoyl)indol | ||
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| JWH-203 | 2-(2-chlorfenyl)-1-(1-pentylindol-3-yl)ethanon | ||
| JWH-210 | (4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-250 | 2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | ||
| JWH-2501 2-methylen-N-methyl-piperidyl derivát | 1-(2-methylen-N-methylpiperidyl)-3-(2-methoxyfenylacetyl)indol | ||
| JWH-251 | 2-(2-methylfenyl)-1-(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-302 | 1-pentyl-3-(3-methoxyfenylacetyl)indol | ||
| JWH-307 | (5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmethanon | ||
| JWH-307 brom derivát | (5-(2-bromfenyl)-1-pentyl-1H-pyrrol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-368 | [5-(3-fluorfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-methanon | ||
| JWH-370 | [5-(2-methylfenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naftalenyl-methanon | ||
| JWH-387 | 1-pentyl-3-(4-brom-1-naftoyl)indol | ||
| JWH-398 | (4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-412 | 1-pentyl-3-(4-fluor-1-naftoyl)indol | ||
| JWH-412 5-fluorpentyl derivát | (4-fluornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]methanon | ||
| JWH-methylcyklohexan-8-chinolinol; BB-22 | chinolin-8-yl 1-(cyklohexylmethyl)-1H-indol-3-karboxylát | ||
| Kathinon | (2S)-2-amino-1-fenylpropan-1-on | ||
| Klobromazolam | phenazolam; BRN 4550445 | 8-brom-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| Klonazolam | 6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Kloniprazepam | 5-(2-chlorfenyl)-1-(cyklopropylmethyl)-7-nitro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-on | ||
| LTI-701 | 1-(5-fluorpentyl)-N-fenyl-indol-3-karboxamid | ||
| LY2183240 | N,N-dimethyl-5-[(4-bifenyl)methyl]tetrazol-1-karboxamid | ||
| M5FPIC | methyl-1-(5-fluorpentyl)-1H-indol-karboxylát | ||
| MAM-2201 | 1-(5-fluorpentyl)-3-(4-methyl-naftoyl)indol | ||
| MAM-2201 chlorpentyl derivát | [1-(5-chlorpentyl)-1H-indol-3-yl](4-methyl-naftalen-1-yl)-methanon | ||
| MBA-CHMINACA | 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3-methylbutanová kyselina | ||
| MBZP | 1 -benzyl-4-methylpiperazin | ||
| MDA 19 | N-[(Z)-(1-hexyl-2-oxoindol-3-yliden)amino]benzamid | ||
| MDAI | 5,6-(methylendioxy)indan-2-amin | ||
| MDMB-4en-PINACA | (methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido) butanoát) | ||
| MDMB-FUBICA | methyl 2-(1-(4-fluorbenzyl)-1H-indol-3-karboxamid)-3,3-dimethylbutanoát | ||
| MDMB-FUBINACA | 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3,3-dimethylbutanoát | ||
| MDMB-CHMCZCA | methyl 2-(9-(cyklohexylmethyl)-9H-karbazol-3-karboxamido)-3,3-dimethylbutanoát | ||
| MDMB-CHMICA | N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl ester | ||
| MDMB-PCZCA | methyl 3,3-dimethyl-2-(9-pentyl-9 H-karbazol-3-karboxamido)butanoát | ||
| MDPHP; 3,4-MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| Meklonazepam | (S)-5-(2-chlorfenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Mepirapim | (4-methylpiperazin-1-yl)-(1-pentylindol-3-yl)methanon | ||
| Meskalin | 3,4,5-trimethoxyfenethylamin | ||
| Metamfepramon | Dimethylkathinon, Dimethylpropion | 2-dimethylamino-1-fenylpropan-1-on | |
| Methamnetamin | methylnaphetamine, N-methyl-PAL-287; MNT; MNA | N-methyl-1-(naftalen-2-yl)propan-2-amin | |
| Methanandamid | N-(2-hydroxy-lR-methylethyl)-5Z,8Z,11Z,14Z-eikosatetraenamid | ||
| Methedron | bk-PMMA | 1-(4-methoxyfenyl)-2-(methylamino)propan-1-on | |
| Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
| Methoxetamin | MXE | 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon | |
| methoxfenidin | MXP | 1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin | 2-MeO-difenidin |
| Methoxpropamin | MXPr, 2-Oxo-3'-methoxy-PCPr | 2-(3-methoxyfenyl)-2-(propylamino)cyklohexan-1-on | |
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| Methylklonazepam | ID 690; ID-690; methylclonazepam; Ro 05-4082; Ro 5-4082 | 5-(2-chlorfenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-on | |
| Methylon | Bk-MDMA | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | |
| Methyltenamfetamin | MDMA | (2R,S)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Methylthienylpropamin | MPA | N-methyl-1-(thiofen-2-yl)propan-2-amin | |
| Metizolam | Desmethyletizolam | 4-(2-chlorfenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| Mexedron | 4-MMC-oMe; MEX | (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on | |
| m-Chlorfenylpiperazin | mCPP | 1-(3-chlorfenyl)piperazin | |
| M-CHMIC | 1-(cyklohexylmethyl)-2-methyl-indol-3-karboxylát | ||
| MN-18 | N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid | ||
| MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyklohexylmethyl)-1H-indazol-3-karboxylát | ||
| MPhP-2201 | methyl 2-{[1-(5-fluorpentyl)-1H-indol-3-yl]formamido}-3-fenylpropanoát | ||
| N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin | |||
| N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin | |||
| Naftylpyrovaleron | Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | O-2482 |
| N-butylhexedron | N-butylnorhexedrone, NBH | 2-(butylamino)-1-fenylhexan-1-on | |
| N-butylpentylon | butyl-pentylone, methylenedioxy-butylvalerophenone, MDBVP | 1-(1,3-benzodioxol-5-yl)-2-(butylamino)pentan-1-on | |
| NEB-inden analog | bk-IBP; , bk-EABDI | 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-on | |
| N-ethylbufedron | NEB | 2-(ethylamino)-1-fenylbutan-1-on | |
| N-ethylheptedron | Ethylheptedrone | 2-(ethylamino)-1-fenyl-heptan-1-on | |
| N-ethylhexedron | HEX-EN; Ethylhexedrone; Ethyl-Hex | 2-(ethylamino)-1-fenyl-hexan-1-on | |
| N-ethyl-isohexedron | NEiH | 2-(ethylamino)-4-methyl-1-fenylpentan-1-on | |
| N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofenon |
| Nifoxipam | 5-(2-fluorfenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-on | ||
| N-isopropylhexedron | NiPH; N-isopropylhexedron | 2-(isopropylamino)-1-fenylhexan-1-on | |
| N-isopropylpentedron | NiPP; NPP, 2-IPP | 2-(isopropylamino)-1-fenylpentan-1-on | |
| Nitrazolam | 1-methyl-8-nitro-6-fenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | ||
| NM-2201, CBL-2201 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát | ||
| N-methyl-2-aminoindan | N-methyl-2AI | 2,3-dihydro-N-methyl-1H-inden-2-amin | NM-2AI |
| N-methylbenzedron | 2-[benzyl(methyl)amino]-1-(4-methylfenyl)propan-1-on | ||
| Norfludiazepam | N-desalkylflurazepam, desalkyl-flurazepam, norflurazepam, Ro 5-3367 | 7-chlor-5-(2-fluorfenyl)-1,3-dihydro-1,4-benzodiazepin-2-on | |
| N-propylnorpentedron | N-propylpentedron | 1-fenyl-2-(propylamino)pentan-1-on | |
| o-Acetylpsilocin | 4-AcO-DMT | {3-[2-(dimethylamino)ethyl]-1H-indol-4-yl }acetát | Psilacetin |
| o-Desmethyltramadol | ODT | 3-{-2-[(dimethylamino)methyl]-1-hydroxycyklohexyl}fenol | |
| Org 27569 | 5-chlor-3-ethyl-N-{2-[4-(1-piperidinyl)fenyl]ethyl}-1H-indol-2-karboxamid | ||
| Org 27759 | 5-fluor-3-ethyl-N-{2-[4-(dimethylamino)fenyl]ethyl}-1H-indol-2-karboxamid | ||
| Org 29647 | 5-chlor-3-ethyl-N-(1-benzylpyrrolidin-3-yl)-3H-indol-2-karboxamid | ||
| Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | ||
| PB-22 indazol analog | chinolin-8-yl-1-pentyl-1H-indazol-3-karboxylát | ||
| Pentedron | 1-fenyl-2-(methylamino)pentan-1-on | ||
| Pentylon | Methylendioxypentedron; βk-MBDP | (±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-on | |
| p-Fluorfenylpiperazin | pFPP | 1-(4-fluorfenyl)piperazin | |
| p-Methyl-4-methylaminorex | 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | p4-DMAR |
| Pravadolin | WIN 48,098 | (4-methoxyfenyl)-[2-methyl-1-(2-morfolin-4-ylethyl)indol-3-yl]methanon | |
| Propylkathinon | N-propylcathinone; PC | 1-fenyl-2-(propylamino)propan-1-on | |
| Propylon | N-propylnormethylone; bk-3,4-MDPA | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-on | |
| Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogenfosfát | ||
| PV8, α-PHPP | 1 -fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on | ||
| PV9, α-POP | 1 -fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | ||
| Pyrazolam | 8-brom-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3 -a] [1,4]benzodiazepin | ||
| RCS-4 | (4-methoxyfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| RCS-4 ortho izomer | (2-methoxyfenyl)(1-pentyl-1H-indol-3-yl)methanon | ||
| RCS-4(C4) | 4-methoxyfeny1-(1-butyl-1H-indol-3-yl)methanon | ||
| Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexyl)pyrrolidin | |
| Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS,10aRS,,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f] isochromen-7-karboxylát | ||
| SDB-005 | naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylát | ||
| SDB-006 | N-benzyl-1-pentyl-1H-indol-3-karboxamid | ||
| SDB-006 N-fenyl analog | 1-pentyl-N-fenyl-1H-indol-3-karboxamid | ||
| STS-135 | N-(1-adamantyl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Tenocyklidin | TCP | 1-[1-(2-thienyl)cyklohexyl]piperidin | |
| Tertylon | tBuONE; MDPT | 1-(1,3-benzodioxol-5-yl)-2-(tert-butylamino)propan-1-on | |
| Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
| Thionordazepam | 7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-thion | ||
| THJ-2201 | 5F-JWH-018-N, 5F-THJ-018, AM-2201 indazol analog | [1-(5-fluorpentyl)-1H-indazol-3-yl] (1 -nařryl)methanon | |
| TH-PBP; 3',4'-tetramethylene-α-PBP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronatalen-2-yl)butan-1-on | ||
| TH-PHP; 2-pyrrohdin-1-yl-1-tetralin-6-yl- hexan-1-on | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)hexan-1-on | ||
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | ||
| trans-CP 47,497-C8 | 5-(1,1-dimethyloktyl)-2-[(1S,3S)-3-hydroxycyklohexyl]-fenol | ||
| Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
| Trimethoxyamfetamin-2 | TMA-2 | (2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
| UR-144(-2H); XLR11 N-(4-pentenyl) derivát | [1-(pent-4-en-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | ||
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 | |
| UR-144 heptyl derivát | (1-heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)-methanon | ||
| UR-144 N-(5-chlorpentyl) derivát | (1-(5-chlorpentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)methanon | ||
| URB-597 | [3-(3-karbamoylfenyl)fenyl]-N-cyklohexylkarbamát | ||
| URB-754 | 6-methyl-2-[(4-methylfenyl)amino]-1-benzoxazin-4-on | ||
| W-15 | 4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid | ||
| W-18 | 4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid | ||
| WIN 55212-2 | (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morfolinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]naftalen-1-ylmethanon | ||
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | ||
| α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
| α-Pyrrolidinoisohexanofenon | α-ΡiΗΡ | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| α-Piperidinbutiofenon | α-PipBP | 1-fenyl-2-(piperidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiofenon | α-PBP | 1-fenyl-2-(pyrrolidin-1-yl)butan-1-on | |
| α-Pyrrolidinbutiothiofenon | α-PBT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)butan-1-on | |
| α-Pyrrolidinnonafenon | α-PNP; PV-10; alpha-pyrrolidi-nononaphenone | 1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on | |
| α-Pyrrolidinpropiofenon | α-PPP | 1-fenyl-2-(pyrrolidin-1-yl)propan-1-on | |
| β-Keto-indanylmethylaminopropan | bk-IMP | 1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on |
Including stereoisomers of psychotropic substances, except for the explicit exceptions listed in this list in all cases where such stereoisomers may exist according to the specific chemical designation and salts of psychotropic substances listed in this list in all cases where they may exist. ';
4. In the table in Annex No 7, under the line in the column entitled "International non-proprietary name (INN) in the Czech language ', the word" Tetrazepam' is inserted, the words "Grandaxin, Emandaxin, EGYT 341 Nodeprine, Seriel, TF 'and the words" 1- (3,4-dimethoxyphenyl) -5-ethyl-7,8- dimethoxy-4- methyl-5H-2,3-benzodiazepine' are inserted in the column entitled "Tofisopam 'and the words" IUPAC' in the column "Chemical name '.
Technical Regulation
This Regulation has been notified in accordance with Directive (EU) 2015 / 1535 of the European Parliament and of the Council of 9 September 2015 laying down a procedure for the provision of information in the field of technical and information society services.
Efficacy
This Regulation shall enter into force on the first day of the calendar month following its publication.
Prime Minister:
Prof. PhDr. Fiala, Ph.D., LL.M., v. r.
Deputy Prime Minister and Minister for Health:
Prof. MUDr. Válek, CSc., MBA, EBIR, v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No. 159 / 2022 Coll., amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended |
|---|---|
| Regulation Type | Regulation |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 22.06.2022 |
|---|---|
| Effective from | 01.07.2022 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0